search
Back to results

The Effect of Anesthesia on Perioperative Muscle Weakness and Neuro-endocrine Stress Response (MUSCLE)

Primary Purpose

Muscle Weakness, Anesthesia, Anesthesia, Local

Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
General anesthesia
Spinal anesthesia
General anesthesia and epidural analgesia
Sponsored by
Ziekenhuis Oost-Limburg
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Muscle Weakness

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 18 years or older.
  • Scheduled for elective total hip arthroplasty or hemicolectomy.

Exclusion Criteria:

  • Lack of informed consent or inability to give informed consent.
  • Urgent surgery, such as hip fracture.
  • Contra-indications for spinal or epidural analgesia, including but not limited to:

    • Infection at the site of puncture.
    • Coagulopathy.
    • Severe hypovolemia.
    • Severe aortic valve stenosis (cross sectional area < 1,3 cm2).
    • Severe mitralis valve stenosis (cross sectional area < 1,0 cm2).
    • Increased intracranial pressure.
    • Pre-existing neurological condition.
    • Severe spine deformity.
    • Sepsis.
    • Body mass index (BMI) > 35 kg/m2
  • Hypersensitivity or known allergic reactions to any products used for anesthesia.
  • History of chronic opioid analgesics use.
  • Preoperative use of steroids:

    • Including, but not limited to: injection of hydrocortisone < 3 months before surgery.
  • Preexisting muscle disease

    • Including, but not limited to: Steinert's disease, amyotrophic lateral sclerosis (ALS), Duchenne dystrophy, amputation of dominant arm or hand.

Sites / Locations

  • Ziekenhuis Oost-Limburg

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Experimental

Arm Label

Hip surgery: spinal anesthesia

Hip surgery: general anesthesia

Colectomy: general anesthesia and epidural analgesia

Colectomy: general anesthesia

Arm Description

Patients scheduled to undergo elective total hip arthroplasty will receive spinal anesthesia in combination with monitored anesthesia care (MAC).

Patients scheduled to undergo elective total hip arthroplasty will receive general anesthesia

Patients scheduled to undergo elective laparoscopic hemicolectomy will receive general anesthesia combined with epidural analgesia (EA).

Patients will receive general anesthesia.

Outcomes

Primary Outcome Measures

Change in post-operative peripheral limb muscle weakness
The strength will be measured in the dominant hand using a Camry handgrip Dynamometer. The measurement will take place on the first day postoperatively, at day 7 and day 28 and will be compared to the preoperative measurement during the preoperative assessment

Secondary Outcome Measures

Change in general health status
Measuring generic health status by the EQ-5D questionnaire preoperatively and at day 1, 7 and 28 after surgery. The general health status is scored by severity ranging from 0 (no problems) to 5 (severe problems)
Change in post-operative lung function: vital capacity
Post-operative lung function at day 1, 7 and 28. The investigators will measure vital capacity (VC). These measurements will take place preoperatively and day 1, 7 and 28 after surgery, using a portable pulmonary function testing machine (PPFTM).
Change in post-operative lung function:forced expiratory volume
Post-operative lung function at day 1, 7 and 28. The investigators will measure forced expiratory volume in 1 second (FEV1). These measurements will take place preoperatively and day 1, 7 and 28 after surgery, using a portable pulmonary function testing machine (PPFTM).
Change in the neuro-endocrine stress response: Cortisol
Blood samples will be taken at the start, end of surgery and the day after surgery to measure cortisol (nmol/L) in the samples
Change in the neuro-endocrine stress response: ACTH
Blood samples will be taken at the start, end of surgery and the day after surgery to measure ACTH (nmol/L) in the samples
Change in the neuro-endocrine stress response: Noradrenaline
Blood samples will be taken at the start, end of surgery and the day after surgery to measure noradrenaline (nmol/L) in the samples
Change in glycemia levels
Measurement of glycemia in the blood.

Full Information

First Posted
June 14, 2018
Last Updated
January 6, 2020
Sponsor
Ziekenhuis Oost-Limburg
search

1. Study Identification

Unique Protocol Identification Number
NCT03600454
Brief Title
The Effect of Anesthesia on Perioperative Muscle Weakness and Neuro-endocrine Stress Response
Acronym
MUSCLE
Official Title
The Effect of Anesthesia on Perioperative Muscle Weakness and Neuro-endocrine Stress Response
Study Type
Interventional

2. Study Status

Record Verification Date
January 2020
Overall Recruitment Status
Completed
Study Start Date
September 1, 2018 (Actual)
Primary Completion Date
December 18, 2019 (Actual)
Study Completion Date
December 30, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ziekenhuis Oost-Limburg

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The effect of surgery, in contrary to critical illness, on muscle weakness hasn't been thoroughly investigated. Recent data suggest that elective surgery may also induce muscle weakness. The neuro-endocrine stress response could be involved in the pathophysiology. Whether the mode of anesthesia/analgesia can influence muscle weakness, by influencing the neuro-endocrine stress response is unknown. Gaining insight in this matter could affect quality of care and benefit patient recovery and satisfaction.
Detailed Description
In this study, the investigators want to demonstrate whether the application of neuraxial anesthesia for elective surgery diminishes perioperative muscle weakness. Since spinal and epidural anesthesia/analgesia have been shown to influence the neuro-endocrine stress response, the possible underlying mediator of perioperative muscle weakness, the investigators will perform two different, but complementary, studies. In one study, patients scheduled for elective total hip arthroplasty will receive spinal anesthesia, without losing consciousness and maintaining a free airway, as compared to receiving general anesthesia. In another study, patients scheduled for a laparoscopic hemicolectomy will receive epidural anesthesia/analgesia during and after the surgery as compared to receiving no epidural anesthesia/analgesia. These studies allow the investigators to identify whether the application of neuraxial anesthesia/analgesia could diminish perioperative weakness and allow us to identify other possible mediators of perioperative muscle weakness, such as losing consciousness or receiving neuromuscular blockade. This study has the potential to help to identify a new side-effect of elective surgery, namely perioperative muscle weakness, and to identify a possible treatment for this possible new complication, namely neuraxial anesthesia and analgesia, which might benefit many patients in the future. Furthermore, investigating the possible mediating role of the neuro-endocrine stress response might identify new therapeutic targets, such as glucagon modulation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Muscle Weakness, Anesthesia, Anesthesia, Local, Surgery

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Two independent, but complimentary, studies will be performed to evaluate the primary objective and the secondary objectives in this prospective trail. Group 1: The effect of spinal anesthesia as compared to general anesthesia for total hip arthroplasty Group 2: The effect of epidural analgesia compared to general anesthesia alone for major abdominal surgery
Masking
Investigator
Masking Description
Patients will be randomized using a computer-generated permuted block randomization sequence (variable block-size, 1:1 allocation). The randomization will be determined on the preoperative anesthesia assessment. After the randomisation, the investigator will inform the patient which anesthesia he/she will get during the operation
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Hip surgery: spinal anesthesia
Arm Type
Experimental
Arm Description
Patients scheduled to undergo elective total hip arthroplasty will receive spinal anesthesia in combination with monitored anesthesia care (MAC).
Arm Title
Hip surgery: general anesthesia
Arm Type
Experimental
Arm Description
Patients scheduled to undergo elective total hip arthroplasty will receive general anesthesia
Arm Title
Colectomy: general anesthesia and epidural analgesia
Arm Type
Experimental
Arm Description
Patients scheduled to undergo elective laparoscopic hemicolectomy will receive general anesthesia combined with epidural analgesia (EA).
Arm Title
Colectomy: general anesthesia
Arm Type
Experimental
Arm Description
Patients will receive general anesthesia.
Intervention Type
Drug
Intervention Name(s)
General anesthesia
Intervention Description
The induction of general anesthesia will be delivered in a standardized manner with the intravenous administration of fentanyl 2µg/kg and propofol
Intervention Type
Drug
Intervention Name(s)
Spinal anesthesia
Intervention Description
The level of puncture will be L4 - L5. 10 mg bupivacaine will be injected in the subarachnoid space, after spontaneous surge of cerebrospinal fluid
Intervention Type
Drug
Intervention Name(s)
General anesthesia and epidural analgesia
Intervention Description
The induction of general anesthesia will be delivered in a standardized manner with the intravenous administration of fentanyl 2 µg/kg and propofol. A thoracic epidural catheter will be placed with 3 ml of xylocaine 2% (with epinephrine 1/200.000).
Primary Outcome Measure Information:
Title
Change in post-operative peripheral limb muscle weakness
Description
The strength will be measured in the dominant hand using a Camry handgrip Dynamometer. The measurement will take place on the first day postoperatively, at day 7 and day 28 and will be compared to the preoperative measurement during the preoperative assessment
Time Frame
Pre-operative (Day 0) and postoperatively (Day 1, Day 7 and Day 28)
Secondary Outcome Measure Information:
Title
Change in general health status
Description
Measuring generic health status by the EQ-5D questionnaire preoperatively and at day 1, 7 and 28 after surgery. The general health status is scored by severity ranging from 0 (no problems) to 5 (severe problems)
Time Frame
Pre-operative (Day 0) and postoperatively (Day1, Day7 and Day28)
Title
Change in post-operative lung function: vital capacity
Description
Post-operative lung function at day 1, 7 and 28. The investigators will measure vital capacity (VC). These measurements will take place preoperatively and day 1, 7 and 28 after surgery, using a portable pulmonary function testing machine (PPFTM).
Time Frame
Pre-operative (Day 0) and postoperatively (Day 1, Day 7 and Day 28)
Title
Change in post-operative lung function:forced expiratory volume
Description
Post-operative lung function at day 1, 7 and 28. The investigators will measure forced expiratory volume in 1 second (FEV1). These measurements will take place preoperatively and day 1, 7 and 28 after surgery, using a portable pulmonary function testing machine (PPFTM).
Time Frame
Pre-operative (Day 0) and postoperatively (Day 1, Day 7 and Day 28)
Title
Change in the neuro-endocrine stress response: Cortisol
Description
Blood samples will be taken at the start, end of surgery and the day after surgery to measure cortisol (nmol/L) in the samples
Time Frame
Pre-operative (Day 0), end of surgery and postoperatively (Day 1)
Title
Change in the neuro-endocrine stress response: ACTH
Description
Blood samples will be taken at the start, end of surgery and the day after surgery to measure ACTH (nmol/L) in the samples
Time Frame
Pre-operative (Day 0), end of surgery and postoperatively (Day 1)
Title
Change in the neuro-endocrine stress response: Noradrenaline
Description
Blood samples will be taken at the start, end of surgery and the day after surgery to measure noradrenaline (nmol/L) in the samples
Time Frame
Pre-operative (Day 0), end of surgery and postoperatively (Day 1)
Title
Change in glycemia levels
Description
Measurement of glycemia in the blood.
Time Frame
Pre-operative (Day 0), end of surgery and postoperatively (Day 1)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 18 years or older. Scheduled for elective total hip arthroplasty or hemicolectomy. Exclusion Criteria: Lack of informed consent or inability to give informed consent. Urgent surgery, such as hip fracture. Contra-indications for spinal or epidural analgesia, including but not limited to: Infection at the site of puncture. Coagulopathy. Severe hypovolemia. Severe aortic valve stenosis (cross sectional area < 1,3 cm2). Severe mitralis valve stenosis (cross sectional area < 1,0 cm2). Increased intracranial pressure. Pre-existing neurological condition. Severe spine deformity. Sepsis. Body mass index (BMI) > 35 kg/m2 Hypersensitivity or known allergic reactions to any products used for anesthesia. History of chronic opioid analgesics use. Preoperative use of steroids: Including, but not limited to: injection of hydrocortisone < 3 months before surgery. Preexisting muscle disease Including, but not limited to: Steinert's disease, amyotrophic lateral sclerosis (ALS), Duchenne dystrophy, amputation of dominant arm or hand.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dimitri Dylst, MD
Organizational Affiliation
Ziekenhuis Oost-Limburg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ziekenhuis Oost-Limburg
City
Genk
ZIP/Postal Code
3600
Country
Belgium

12. IPD Sharing Statement

Learn more about this trial

The Effect of Anesthesia on Perioperative Muscle Weakness and Neuro-endocrine Stress Response

We'll reach out to this number within 24 hrs